YoVDO

The Era of ADCs in the Treatment of NSCLC

Offered By: HMP Education via YouTube

Tags

Oncology Courses Clinical Trials Courses Cancer Treatment Courses Precision Medicine Courses Drug Development Courses Biomarkers Courses Targeted Therapy Courses Immunotherapy Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore the evolving landscape of antibody-drug conjugates (ADCs) in non-small cell lung cancer (NSCLC) treatment through this informative 33-minute video. Gain insights into the latest advancements, clinical applications, and potential benefits of ADCs in improving outcomes for NSCLC patients. Delve into the mechanisms of action, efficacy data, and safety profiles of emerging ADC therapies. Understand how these targeted treatments are reshaping the therapeutic approach to NSCLC and their implications for patient care. Healthcare professionals can earn Continuing Medical Education (CME) credits by completing the associated program.

Syllabus

The Era of ADCs in the Treatment of NSCLC


Taught by

HMP Education

Related Courses

Demystifying Targeted Cancer Treatments
Cancer Research UK via FutureLearn Viruses and Human Cancers
Institut Pasteur via France Université Numerique Introduction à l'immunologie: méthodes et applications médicales
École Polytechnique Fédérale de Lausanne via edX Foundations of Understanding and Combating Cancer
Cornell University via World Science U Medicine Grand Rounds - Immune-Related Toxicities with Immune Checkpoint Inhibitors
Dartmouth College via Independent